← Back to Search

Laser Therapy

Phoenix Thera-Lase System 42 for Pain

N/A
Waitlist Available
Led By Paul F White, PhD, MD
Research Sponsored by Phoenix Thera-lase Systems, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month
Awards & highlights

Study Summary

Hypothesis: Use of high level vs low level cold laser treatments will reduce chronic pain and the need for PRN opioid-containing analgesic medications. Secondary Hypothesis: High level (vs low level) laser treatments will increase the patients level of physical activity and quality of sleep.

Eligible Conditions
  • Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduce chronic pain
reduce of opioid analgesic dosage.
Secondary outcome measures
Level of physical activity
Quality of sleep

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Phoenix Thera-Lase System 74Experimental Treatment1 Intervention
The Phoenix Thera-Lase System will be on 74 watts while retaining appropriate "blinding" of both the operator and the patient. Treatments will be applied to the primary area of the body associated with pain for which analgesic (pain) medication is currently required. Each treatment session will last for 20-40 minutes.
Group II: Phoenix Thera-Lase System 42Experimental Treatment1 Intervention
The Phoenix Thera-Lase System will be on 42 watts while retaining appropriate "blinding" of both the operator and the patient. Treatments will be applied to the primary area of the body associated with pain for which analgesic (pain) medication is currently required. Each treatment session will last for 20-40 minutes.
Group III: Low level 1 WattActive Control1 Intervention
The Phoenix Thera-Lase System will be on 1 watt while retaining appropriate "blinding" of both the operator and the patient. Treatments will be applied to the primary area of the body associated with pain for which analgesic (pain) medication is currently required. Each treatment session will last for 20-40 minutes.

Find a Location

Who is running the clinical trial?

Phoenix Thera-lase Systems, LLCLead Sponsor
Paul F White, PhD, MDPrincipal InvestigatorPhoenix Thera-Lase Systems

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis
Paul F. White 2016. "Phoenix Thera-Lase for Treating Chronic Pain in Patients Taking Opioid on a PRN Basis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02964000.
All > American Chronic Pain
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top